文献速递肝病

经组织学证实的酒精相关肝病自然史:系统综述

Natural history of histologically proven alcohol-related liver disease: A systematic review.
PubMed 文献 · J Hepatol · 2019-06-05

危险饮酒者中平均15%组织学正常、27%脂肪变、24%脂肪性肝炎、26%肝硬化;脂肪性肝炎年化死亡率入院队列15%、混合队列5%,脂肪变年化死亡率6%,仅脂肪变非肝病死亡超过肝病死亡。

要点

  • 组织学正常、脂肪变、脂肪性肝炎、纤维化年化进展至肝硬化率分别为1%、3%、10%、8%。
  • 脂肪性肝炎需入院者年化死亡率15%,混合队列为5%。
  • 脂肪变年化死亡率6%,非肝病死亡5%/年超过肝病死亡1%/年。

核心结论

  • 酒精相关肝脂肪性肝炎需住院是最危险的ALD亚型。
  • 酒精相关脂肪变并非良性,与显著死亡风险相关。

研究设计与样本

  • 采用单比例meta分析合并进展率与死亡率数据。

主要发现

  • 危险饮酒者中平均15%组织学正常、27%肝脂肪变、24%脂肪性肝炎、26%肝硬化。
  • 癌前病变年化进展至肝硬化率:组织学正常1%(0-8%)、脂肪变3%(2-4%)、脂肪性肝炎10%(6-17%)、纤维化8%(3-19%)。
  • 年化死亡率:脂肪变6%(4-7%),肝硬化8%(5-13%)。
  • 活检示脂肪性肝炎者,入院队列年化死亡率15%(8-26%),住院与门诊混合队列为5%(2-10%)。
  • 仅脂肪变患者非肝病死亡率超过肝病特异死亡率(5%/年 vs 1%/年)。

临床怎么用

  • 可依据组织学阶段向患者说明年化肝硬化进展风险与年化死亡风险。
  • 对需住院的酒精相关脂肪性肝炎应认识其为ALD中最危险亚型。
  • 对酒精相关脂肪变不应视为良性,需关注其显著死亡风险。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: To date, studies into the natural history of alcohol-related liver disease (ALD) have lacked long-term follow-up, large numbers of participants, or both. We performed a systematic review to summarise studies that describe the natural history of histologically proven ALD. METHODS: PubMed and Medline were searched for relevant studies according to pre-specified criteria. Data were extracted to describe the prevalence of ALD, histological progression of disease and mortality. Single-proportion meta-analysis was used to combine data from studies regarding rates of progression or mortality. RESULTS: Thirty-seven studies were included, reporting data from 7,528 participants. Amongst cohorts of hazardous drinkers, on average 15% had normal histological appearance, 27% had hepatic steatosis, 24% had steatohepatitis and 26% had cirrhosis. The annualised rates of progression of pre-cirrhotic disease to cirrhosis were 1% (0-8%) for patients with normal histology, 3% (2-4%) for hepatic steatosis, 10% (6-17%) for steatohepatitis and 8% (3-19%) for fibrosis. Annualised mortality was 6% (4-7%) in patients with steatosis and 8% (5-13%) in cirrhosis. In patients with steatohepatitis on biopsy a marked difference was seen between inpatient cohorts (annual mortality 15%, 8-26%) and mixed cohorts of inpatients and outpatients (annual mortality 5%, 2-10%). Only in steatosis did non-liver-related mortality exceed liver-specific causes of mortality (5% per year vs. 1% per year). CONCLUSIONS: These data confirm the observation that alcohol-related hepatic steatohepatitis requiring admission to hospital is the most dangerous subtype of ALD. Alcohol-related steatosis is not a benign condition as it is associated with significant risk of mortality. LAY SUMMARY: Knowledge of the natural history of a disease allows clinicians and patients to understand the risks that are associated with a medical condition. In this study we systematically gathered all the published data regarding the natural history of alcohol-related liver disease in people who had a liver biopsy. We used this data to define the prevalence of the disease, the annual risk of progression to cirrhosis and the annual risk of death at each stage of the disease.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Parker R, Aithal GP, Becker U, et al. Natural history of histologically proven alcohol-related liver disease: A systematic review. J Hepatol. 2019. PMID: 31173814. doi:10.1016/j.jhep.2019.05.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。